Reaction Details 
Report a problem with these data
Report a problem with these dataTarget
E3 ubiquitin-protein ligase Mdm2 [17-125]
Ligand
BDBM224650
Substrate
n/a
Meas. Tech.
FRET Assay
Temperature
298.15±n/a K
IC50
0.7627±n/a nM
Comments
extracted
Citation
Cammarano, CM; Christopher, MP; Dinsmore, C; Doll, RJ; Fradera Llinas, FX; Li, C; Machacek, M; Martinez, M; Nair, LG; Pan, W; Reutershan, MH; Shizuka, M; Steinhuebel, DP; Sun, B; Thompson, CF; Trotter, BW; Wang, Y; Yang, L; Bogen, SL; Voss, ME; Panda, J; Kurissery, AT 2,6,7,8 substituted purines as HDM2 inhibitors US Patent US9540377 Publication Date 1/10/2017More Info.:
Target
Name:
E3 ubiquitin-protein ligase Mdm2 [17-125]
Synonyms:
Double minute 2 protein | E3 ubiquitin-protein ligase Mdm2 | MDM2 | MDM2_HUMAN | p53-binding protein Mdm2
Type:
Enzyme Catalytic Domain
Mol. Mass.:
12522.24
Organism:
Homo sapiens (Human)
Description:
Residue 17 to 125
Residue:
109
Sequence:
SQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN
Inhibitor
Name:
BDBM224650
Synonyms:
3-[6-{[(1r)-1- cyclobutylethyl]amino}-7- [(trans-4- methylcyclohexyl)methyl]- 8-(phenylsulfanyl)-7h- purin-2-yl]-1,2,4- oxadiazol-5(4h)-one | US9540377, 19.1
Type:
Small organic molecule
Emp. Form.:
C27H33N7O2S
Mol. Mass.:
519.662
SMILES:
C[C@@H](Nc1nc(nc2nc(Sc3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)-c1noc(=O)[nH]1)C1CCC1 |r,wU:1.0,19.19,wD:22.23,(-4.31,-1.82,;-2.98,-2.59,;-1.64,-1.82,;-1.64,-.28,;-2.98,.49,;-2.98,2.03,;-1.64,2.8,;-.31,2.03,;1.16,2.51,;2.06,1.26,;3.6,1.26,;4.37,2.6,;5.91,2.6,;6.68,3.93,;5.91,5.26,;4.37,5.26,;3.6,3.93,;1.16,.02,;1.16,-1.52,;2.49,-2.29,;3.82,-1.52,;5.16,-2.29,;5.16,-3.83,;6.49,-4.6,;3.82,-4.6,;2.49,-3.83,;-.31,.49,;-4.31,2.8,;-5.78,2.33,;-6.68,3.57,;-5.78,4.82,;-6.17,6.31,;-4.31,4.34,;-2.98,-4.13,;-4.07,-5.22,;-2.98,-6.31,;-1.89,-5.22,)|
Structure:
